Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Leverkus

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 26, 2012
Malignant epithelial tumors: Part I. Pathophysiology and clinical featuresMartin Leverkus
Journal of Skin Cancer|January 22, 2011
Basal cell carcinoma: from the molecular understanding of the pathogenesis to targeted therapy of progressive diseaseDaniela Göppner, Martin Leverkus
The Journal of Investigative Dermatology|January 24, 2016
Guiding the Killer and Bringing in Accomplices: Bispecific Antibody Treatment for Malignant MelanomaEva Szegezdi, Martin Leverkus
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 5, 2013
Malignant epithelial tumors: Part II. Therapy and preventionIoannis Manousaridis, Martin Leverkus
The Journal of Investigative Dermatology|October 17, 2006
CD95-mediated signals in the skin: going out with an (inflammatory) bang?Martin Leverkus, Axel Trautmann
The Journal of Investigative Dermatology|May 17, 2006
"Bak (and Bax) to the future"--of primary melanoma prognosis?Martin Leverkus, Harald Gollnick
The FEBS Journal|October 21, 2014
Programmed necrosis and necroptosis signallingMaria Feoktistova, Martin Leverkus
Journal of Skin Cancer|October 19, 2011
Prognostic parameters for the primary care of melanoma patients: what is really risky in melanoma?Daniela Göppner, Martin Leverkus
Cold Spring Harbor Protocols|April 3, 2016
Crystal Violet Assay for Determining Viability of Cultured CellsMaria Feoktistova, Peter Geserick, Martin Leverkus
Experimental Dermatology|July 16, 2009
Effector pathways during eczematous dermatitis: where inflammation meets cell deathAndreas Kerstan, Martin Leverkus, Axel Trautmann
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 26, 2012
Malignant epithelial tumors: Part I. Pathophysiology and clinical featuresMartin Leverkus
Journal of Skin Cancer|January 22, 2011
Basal cell carcinoma: from the molecular understanding of the pathogenesis to targeted therapy of progressive diseaseDaniela Göppner, Martin Leverkus
The Journal of Investigative Dermatology|January 24, 2016
Guiding the Killer and Bringing in Accomplices: Bispecific Antibody Treatment for Malignant MelanomaEva Szegezdi, Martin Leverkus
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 5, 2013
Malignant epithelial tumors: Part II. Therapy and preventionIoannis Manousaridis, Martin Leverkus
The Journal of Investigative Dermatology|October 17, 2006
CD95-mediated signals in the skin: going out with an (inflammatory) bang?Martin Leverkus, Axel Trautmann
The Journal of Investigative Dermatology|May 17, 2006
"Bak (and Bax) to the future"--of primary melanoma prognosis?Martin Leverkus, Harald Gollnick
The FEBS Journal|October 21, 2014
Programmed necrosis and necroptosis signallingMaria Feoktistova, Martin Leverkus
Journal of Skin Cancer|October 19, 2011
Prognostic parameters for the primary care of melanoma patients: what is really risky in melanoma?Daniela Göppner, Martin Leverkus
Cold Spring Harbor Protocols|April 3, 2016
Crystal Violet Assay for Determining Viability of Cultured CellsMaria Feoktistova, Peter Geserick, Martin Leverkus
Experimental Dermatology|July 16, 2009
Effector pathways during eczematous dermatitis: where inflammation meets cell deathAndreas Kerstan, Martin Leverkus, Axel Trautmann
Pageof 8